Uzbekistan

in page functions: [French]

Total population (2018)	31,063,045
Birth cohort (2018)	639,247
Surviving Infants (surviving to 1 year per year, 2018)	613,395
Infant mortality rate (deaths < 1 year per 1000 births, 2015)	34/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015)	39/1000
World Bank Index, IDA (2015)	3.43
Gross Nation Income (per capita US$, 2015)	2,160
Co-financing group (2018)	Accelerated transition
No. of districts/territories (2017)	201

Download this page as a PDF factsheet

Uzbekistan

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Uzbekistan

Type of support	Approvals 2001-2023 (US$) (26 Sep 2018)	Commitments 2001-2023 (US$) (26 Sep 2018)	Disbursements 2000-2018 (US$) (26 Sep 2018)	% Disbursed (26 Sep 2018)


Total	$74,839,864	$87,812,844	$77,008,886
Cold Chain Equipment Optimisation Platform (CCEOP)	$1,204,849	$1,204,849
Graduation grant (GG)	$833,940	$833,940	$833,940	100%
Health system strengthening (HSS 1)	$7,380,000	$17,218,480	$7,380,000	100%
HepB mono (NVS)	$4,358,659	$4,358,659	$4,358,659	100%
HPV (NVS)				N/A
Immunisation services support (ISS)				N/A
Injection Safety Devices (NVS)	$155,875	$180,875	$172,672	111%
Injection safety support (INS)	$727,012	$727,012	$727,012	100%
IPV (NVS)	$1,556,368	$1,556,368	$1,176,678	76%
Penta (NVS)	$31,429,395	$31,910,895	$32,017,640	102%
Pneumo (NVS)	$17,935,201	$20,563,201	$20,915,888	117%
Rotavirus (NVS)	$7,465,565	$7,465,565	$7,633,897	102%
Vaccine Introduction Grant (VIG)	$1,793,000	$1,793,000	$1,792,500	100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Uzbekistan DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017) Grade of confidence	N/A
DTP3 - Official country estimates (2017)	99%
M:F sex ratio at birth (2018)	1.06
Household survey: DTP3 coverage for male (2005)	93.50%
Household survey: DTP3 coverage for female (2005)	92.80%
Household survey: Last DTP3 survey (2005)	93%
% districts achieving > 80% DTP3 coverage (2017)	100%
% districts achieving < 50% DTP3 coverage (2017)	0%
MCV WHO/UNICEF estimates (2017)	99%

Breakdown of support

Non-vaccine support	Vaccine support
14%	86%
$10,733,452	$66,275,434

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Uzbekistan

11 November 2016

Fighting pneumonia in Nepal: making numbers count

At Kathmandu’s Patan hospital, Gavi is funding impact studies on two vaccines that protect children against the main causes of deadly pneumonia: Haemophilus influenzae type b (Hib) and pneumococcal disease. Three doctors who are leading these studies identify four ways in which Patan’s pioneering research is shaping Nepal’s immunisation policy.

08 March 2014

1.5 million girls set to benefit from vaccine against cervical cancer

GAVI Alliance support for national introductions marks new HPV vaccine milestone on International Women’s Day.

05 October 2012

Useful information

Useful information for anyone attending the Partners' Forum in Tanzania: Climate, Passports & Visas, Health, Safety, General behaviour in public, Currency, Tipping, Electricity, Shopping

Useful links

View all sources for data in this page

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.